Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 21, 2016; 22(27): 6224-6234
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6224
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6224
Table 1 Clinical characteristics of the study subjects
Hepatitis B-associated HCC(n = 30) | Hepatitis C-associated HCC(n = 38) | P value | |
Sex (M/F) | 28/2 | 22/16 | < 0.011 |
Age (yr) | 62.6 ± 10.9 | 73.4 ± 9.7 | < 0.012 |
Albumin (g/dL) | 3.4 ± 0.6 | 3.4 ± 0.5 | NS2 |
Total bilirubin (mg/dL) | 1.2 ± 0.6 | 1.4 ± 1.3 | NS2 |
AST (U/L) | 75.6 ± 76.2 | 57.8 ± 31.6 | NS2 |
ALT (U/L) | 54.3 ± 38.4 | 49.8 ± 38.3 | NS2 |
Fasting blood glucose (mg/dL) | 104.5 ± 22.2 | 113.1 ± 36.0 | NS2 |
γ-glutamyl transferase (U/L) | 77.0 ± 64.8 | 60.4 ± 58.1 | NS2 |
Creatinine (mg/dL) | 0.73 ± 0.19 | 1.01 ± 1.53 | NS2 |
Platelet count (× 103/μL) | 13.5 ± 8.4 | 11.7 ± 4.7 | NS2 |
Fib-4 index | 5.7 ± 4.4 | 6.4 ± 3.9 | NS2 |
AFP (ng/mL) ≤ 6.2 /> 6.2 | 10/20 | 8/30 | NS1 |
DCP (mAU/mL) ≤ 40 /> 40 | 17/13 | 24/14 | NS1 |
HBs antigen, positive | 30 | 0 | |
HCV-antibody, positive | 0 | 38 | |
HBV genotype (A/B/C/D) | 0/14/15/1 | NA | |
HCV genotype (1b/2a/2b) | NA | 34/4/0 |
Table 2 Parameters of multiple logistic regression model
Metabolite | Coefficient | 95%CI | Odds ratio | 95%CI | P value | ||
(Intercept) | -8.01 | -14.0 | -4.14 | 1.00 × 10-3 | |||
Met | 0.0521 | 0.018 | 0.0979 | 1.05 | 1.02 | 1.10 | 8.60 × 10-3 |
γ-Glu-Gly-Gly | -17.6 | -35.7 | -5.31 | 2.23 × 10-8 | 3.18 × 10-16 | 4.93 × 10-3 | 1.97 × 10-2 |
Glu | 0.0255 | 0.0135 | 0.0454 | 1.03 | 1.01 | 1.05 | 1.30 × 10-3 |
Table 3 Correlation coefficients between amino acids and γ-glutamyl peptides
Amino acid | γ-glutamyl peptides | Spearman R | 95%CI | P value(two-tailed) |
Ile | γ-Glu-Ile | 0.4584 | 0.2401-0.6325 | < 0.0001 |
Ala | γ-Glu-Ala | 0.04022 | -0.4898 | 0.7447 |
Ser | γ-Glu-Ser | 0.2117 | -0.4698 | 0.0831 |
Val | γ-Glu-Val | 0.4565 | 0.2379-0.6311 | < 0.0001 |
Thr | γ-Glu-Thr | 0.3909 | 0.1610-0.5805 | 0.001 |
Leu | γ-Glu-Leu | 0.4898 | 0.2779-0.6562 | < 0.0001 |
Asn | γ-Glu-Asn | 0.4012 | 0.1729-0.5885 | 0.0007 |
Lys | γ-Glu-Lys | 0.2909 | 0.04915-0.5004 | 0.0161 |
Gln | γ-Glu-Gln | 0.6387 | 0.4665-0.7642 | < 0.0001 |
Glu | γ-Glu-Glu | 0.8268 | 0.7294-0.8913 | < 0.0001 |
His | γ-Glu-His | 0.2982 | 0.05714-0.5064 | 0.0135 |
Phe | γ-Glu-Phe | 0.4886 | 0.2765-0.6554 | < 0.0001 |
Arg | γ-Glu-Arg | 0.4258 | 0.2016-0.6076 | 0.0003 |
Tyr | γ-Glu-Tyr | 0.6937 | 0.5404-0.8024 | < 0.0001 |
Asp | γ-Glu-Asp | 0.5566 | 0.3606-0.7056 | < 0.0001 |
Met | γ-Glu-Met | 0.5418 | 0.3420-0.6947 | < 0.0001 |
Trp | γ-Glu-Trp | 0.3433 | 0.1070-0.5428 | 0.0042 |
Gly | γ-Glu-Gly | 0.05704 | -0.489 | 0.6441 |
Gly | γ-Glu-Gly-Gly | 0.006012 | -0.4905 | 0.9612 |
- Citation: Saito T, Sugimoto M, Okumoto K, Haga H, Katsumi T, Mizuno K, Nishina T, Sato S, Igarashi K, Maki H, Tomita M, Ueno Y, Soga T. Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C. World J Gastroenterol 2016; 22(27): 6224-6234
- URL: https://www.wjgnet.com/1007-9327/full/v22/i27/6224.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i27.6224